| Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study BE Young, SW Fong, YH Chan, TM Mak, LW Ang, DE Anderson, CYP Lee, ... The lancet 396 (10251), 603-611, 2020 | 461 | 2020 |
| Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients CM Poh, G Carissimo, B Wang, SN Amrun, CYP Lee, RSL Chee, ... Nature communications 11 (1), 2806, 2020 | 377 | 2020 |
| Serological approaches for COVID-19: epidemiologic perspective on surveillance and control CYP Lee, RTP Lin, L Renia, LFP Ng Frontiers in immunology 11, 548159, 2020 | 313 | 2020 |
| Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19 G Carissimo, W Xu, I Kwok, MY Abdad, YH Chan, SW Fong, KJ Puan, ... Nature communications 11 (1), 5243, 2020 | 158 | 2020 |
| Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data G Thomalla, F Boutitie, H Ma, M Koga, P Ringleb, LH Schwamm, O Wu, ... The Lancet 396 (10262), 1574-1584, 2020 | 137 | 2020 |
| Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity SN Amrun, CYP Lee, B Lee, SW Fong, BE Young, RSL Chee, NKW Yeo, ... EBioMedicine 58, 2020 | 126 | 2020 |
| Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections YW Kam, CYP Lee, TH Teo, SW Howland, SN Amrun, FM Lum, P See, ... JCI insight 2 (8), 2017 | 89 | 2017 |
| Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19 YS Goh, JM Chavatte, AL Jieling, B Lee, PX Hor, SN Amrun, CYP Lee, ... Cell Reports Medicine 2 (2), 2021 | 48 | 2021 |
| Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2 YH Chan, SW Fong, CM Poh, G Carissimo, NKW Yeo, SN Amrun, YS Goh, ... EMBO molecular medicine 13 (6), e14045, 2021 | 47 | 2021 |
| Potent neutralizing antibodies in the sera of convalescent COVID-19 patients are directed against conserved linear epitopes on the SARS-CoV-2 spike protein CM Poh, G Carissimo, B Wang, SN Amrun, CYP Lee, RSL Chee, ... BioRxiv, 2020.03. 30.015461, 2020 | 47 | 2020 |
| Zika virus infection preferentially counterbalances human peripheral monocyte and/or NK cell activity FM Lum, D Lee, TK Chua, JJL Tan, CYP Lee, X Liu, Y Fang, B Lee, ... MSphere 3 (2), 10.1128/mspheredirect. 00120-18, 2018 | 36 | 2018 |
| Plasmodium co-infection protects against chikungunya virus-induced pathologies TH Teo, FM Lum, K Ghaffar, YH Chan, SN Amrun, JJL Tan, CYP Lee, ... Nature communications 9 (1), 3905, 2018 | 33 | 2018 |
| Zika virus: from an obscurity to a priority CYP Lee, LFP Ng Microbes and infection 20 (11-12), 635-645, 2018 | 32 | 2018 |
| Viperin controls chikungunya virus–specific pathogenic T cell IFNγ Th1 stimulation in mice G Carissimo, TH Teo, YH Chan, CYP Lee, B Lee, A Torres-Ruesta, ... Life science alliance 2 (1), 2019 | 28 | 2019 |
| Signatures of mast cell activation are associated with severe COVID-19 J Tan, DE Anderson, APS Rathore, A O’Neill, CK Mantri, WAA Saron, ... medRxiv, 2021.05. 31.21255594, 2021 | 24 | 2021 |
| Mutating chikungunya virus non‐structural protein produces potent live‐attenuated vaccine candidate YH Chan, TH Teo, A Utt, JJL Tan, SN Amrun, F Abu Bakar, WX Yee, ... EMBO Molecular Medicine 11 (6), e10092, 2019 | 24 | 2019 |
| Immunological observations and transcriptomic analysis of trimester‐specific full‐term placentas from three Zika virus‐infected women FM Lum, V Narang, S Hue, J Chen, N McGovern, R Rajarethinam, ... Clinical & translational immunology 8 (11), e01082, 2019 | 24 | 2019 |
| Robust virus-specific adaptive immunity in COVID-19 patients with SARS-CoV-2 Δ382 variant infection SW Fong, NKW Yeo, YH Chan, YS Goh, SN Amrun, N Ang, ... Journal of Clinical Immunology, 1-16, 2022 | 20 | 2022 |
| Serological approaches for COVID-19: Epidemiologic perspective on surveillance and control. Front Immunol. 2020; 11: 879 CY Lee, RTP Lin, L Renia, LFP Ng | 20 | 2020 |
| Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant CYP Lee, SN Amrun, RSL Chee, YS Goh, TM Mak, S Octavia, NKW Yeo, ... Clinical & translational immunology 10 (2), e1241, 2021 | 16 | 2021 |
